Gradually increased oxygen administration (GIOA) seems promising in hemorrhagic shock. However, the effects of GIOA on survival remain unclear, and details of GIOA are to be identified. After the induction of hemorrhagic shock, the rats were randomized into five groups (n ¼ 9): normoxic group (Normo), hyperoxic group (Hypero), normoxic to hyperoxic group (GIOA1), longtime hypoxemic to hyperoxic group (GIOA2), and short-time hypoxemic to hyperoxic group (GIOA3). Survival was recorded for 96 h, plasma alanine transaminase, oxidative stress, hemodynamics, and blood gas were measured. The mean survival time of the GIOA3 was significantly longer than that of the Normo, Hypero, and GIOA2. Plasma alanine transaminase levels were significantly lower in the Normo, GIOA1, and GIOA3 compared to the Hypero and GIOA2 at 2 h post-resuscitation (PR). Plasma 3-nitrotyrosine levels at 2 h PR were significantly lower in the GIOA2 and GIOA3 compared to the Normo and Hypero. Central venous oxygen saturation at 2 h PR in the GIOA3 was significantly higher than the Normo; however, no significant difference was observed between GIOA1 and Normo. Besides, at 2 h PR, mean arterial pressure in the GIOA3 was significantly higher than the GIOA2; however, no significant difference was observed between GIOA1 and GIOA2. (1) GIOA could significantly prolong survival time compared to normoxemic resuscitation and hyperoxic resuscitation; (2) early moments of GIOA are critical to the benefits; and (3) hypoxemia at onset of resuscitation may be imperative, more works are needed to determine the optimal initial oxygen concentration of GIOA.
Introduction
Hemorrhagic shock (HS) is one of the major causes of death in trauma. HS impairs oxygen delivery, causes cellular and tissue hypoxia, and may ultimately result in multiple organ dysfunction syndrome (MODS). 1, 2 To restore tissue and systemic oxygenation as soon as possible, hyperoxic resuscitation has been the routine method during clinical HS management. [3] [4] [5] However, the potential side effects of hyperoxic resuscitation could offset the benefits, too much oxygen may be associated with vasoconstriction and the oxidative burst. [6] [7] [8] To alleviate oxidative injury during resuscitation from HS, hypoxemic resuscitation was proposed. 9 However, it may be accompanied with inadequate oxygen delivery. Thereafter, it is necessary to develop new oxygen administration strategy to improve resuscitation from HS.
In our previous study, 10 we proposed and evaluated gradually increased oxygen administration (GIOA, gradual acclimatization from hypoxemia to hyperoxia), which was found to ameliorate blood pressure, acid-base status, and oxygenation to an extent comparable to hyperoxic resuscitation, and mitigate oxidative stress to an extent comparable to hypoxemic resuscitation.
However, the effects of GIOA on survival remain unclear; and details of GIOA, such as whether hypoxemia at onset of resuscitation is imperative and the optimal timing of hypoxemic status are to be identified. We hypothesized that GIOA would promote survival, and hypoxemia at the early moments of resuscitation is critical to the benefits of GIOA in a rat HS model.
Materials and methods
The experimental protocol was approved by the Institutional Animal Care and Use Committee of the Academy of Military Medical Sciences, and conforms to the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. Eight-week-old male Wistar (300-340 g) rats were purchased from Vital River (Beijing, China). They fasted overnight but were allowed water ad libitum before experiments.
HS model
The HS model was performed as previously described. 10 Briefly, anesthesia was induced with sodium pentobarbital (50 mg/kg intraperitoneally), and was maintained every 90 min (20 mg/kg). The left femoral artery and vein were cannulated for blood withdrawal and drug infusions, the right femoral artery was cannulated for mean arterial pressure (MAP) monitoring, and the superior vena cava was cannulated for central venous blood collection. To prevent blood coagulation, 400 U/kg of heparin was administrated before bleeding, and 100 U/kg was administrated after resuscitation. Rats were bled to an MAP of 38 mmHg at the rate of 0.4 mL/min using a syringe pump (LZS -AJ10, Softron, Beijing, China), and this pressure was thereafter maintained at 35-40 mmHg for 60 min by reinfusion of the shed blood or further withdrawal at the rate of 0.3 mL/min.
Experimental groups
At the end of the HS, the rats were randomly assigned to one of the five groups (n ¼ 9): the normoxic group (Normo) in which the fraction of inspiration O 2 (FiO 2 ) was 0.210; the hyperoxic group (Hypero) in which the FiO 2 was 0.500; the GIOA group 1 (GIOA1), in which the FiO 2 increased from 0.210 to 0.500 by 0.058 per 20 min; the GIOA group 2 (GIOA2), in which the FiO 2 increased from 0.165 to 0.210 by 0.015 per 20 min, and from 0.210 to 0.500 by 0.058 per 10 min; and the GIOA group 3 (GIOA3), in which the FiO 2 increased from 0.165 to 0.210 by 0.015 per 10 min, and from 0.210 to 0.500 by 0.058 per 15 min ( Figure 1 ). The way FiO 2 changed was described in detail in our previous study. 10 Meanwhile, the rats were resuscitated with three times the shed blood volume as Lactated Ringer's solution over a 2-h period. Experiments were continued 2 h after resuscitation for observation. At 2 h post-resuscitation (PR), the rats were sewed up, and moved to a regular cage. Survival was observed up to 96 h PR.
Measurement of hemodynamics and blood gases
Hemodynamics was continuously monitored via a multiple-channel recorder (MP150 Research System, Biopac System Inc., Montreal, Canada) throughout the experiment. At baseline (BL), post-hemorrhagic shock (PS), 1 h after the initiation of resuscitation (R), 2 h R, 1 h PR, and 2 h PR, 0.1 mL arterial blood and 0.1 mL central venous blood were drawn for the test of blood gases, separately. Blood gases were analyzed using a blood gas analyzer (ABL90, Radiometer, Copenhagen, Denmark) for central venous oxygen saturation (ScvO 2 ).
Test for plasma alanine transaminase and aspartate transaminase
To test plasma alanine transaminase (ALT), aspartate transaminase (AST), and oxidative stress, additional 2.3 mL arterial blood were drawn at 2 h PR, and then centrifuged at 1500g 4 C for 15 min. The drawn blood was replaced by a 1:1 volume of shed blood at all time points. The extracted plasma at 2 h PR were analyzed by measuring plasma ALT and AST using a biochemistry automatic analyzer (7180 Clinical Analyzer, Hitachi, Tokyo, Japan). 
Test of oxidative stress
Plasma samples were tested with 3-nitrotyrosine (3-NT) assay kit (Z062SC, Elixir Canada Medicine Company Ltd, Vancouver, Canada) according to the manufacturer's instructions. SpectraMax M5 spectrophotometer (Molecular Devices, Sunnyvale, USA) was used.
Statistical analyses
All variables are presented as the mean AE SD. SAS 9.2 (SAS Institute Inc., Cary, NC) was used for statistical analysis. The investigators were blinded to the experimental group assignment: the people who adjusted the FiO 2 , the people who recorded the data and the people who analyzed the data were all different. Since survival was the primary outcome variable, statistical power analysis was used to guide sample size estimation based on the survival ( ¼ 0.05, power ¼ 80%). For ScvO 2 and MAP, two-way ANOVA repeated measures was used to compare the differences between groups and their interaction at various time points. For plasma 3-NT levels and organ function, ANOVA with Student-Newman-Keuls post hoc testing was used. Kaplan-Meier analysis was used to estimate survival. Differences were considered significant when P < 0.05.
Results

Effects on survival
Five rats (5/9) in the GIOA3 survived up to 96 h, compared to 1/9, 2/9, 3/9, and 1/9 in the Normo, Hypero, GIOA1, and GIOA2, respectively ( Figure 2 ). The mean survival time of the GIOA3 (53.3 AE 6.5 h) was significantly longer than that of the Normo (25.3 AE 4.9 h), Hypero (24.5 AE 4.9 h), and GIOA2 (25.7 AE 10.2 h). The mean survival time of the GIOA1 was 40.1 AE 6.5 h.
Effects on ALT and AST
At 2 h PR, ALT concentration was significantly lower in the Normo (81 AE 24 U/L), GIOA1 (87 AE 38 U/L), and GIOA3 (75 AE 16 U/L) compared to the Hypero (116 AE 42 U/L) and GIOA2 (154 AE 59 U/L) (P < 0.05) ( Figure 3a ). Plasma AST concentration did not differ significantly between the groups at 2 h PR ( Figure 3b ). ScvO 2 decreased from BL to PS similarly in all groups, and recovered upon resuscitation ( Figure 5 ). At 1 h R, ScvO 2 in the Hypero (46.4 AE 8.0%) was significantly higher than the Normo (35.9 AE 5.6%), GIOA2 (31.7 AE 7.0%), and GIOA3 (39.2 AE 7.0%) (P < 0.05, respectively). At 2 h R, ScvO 2 in the Hypero (47.7 AE 12.8%) and GIOA groups were significantly higher than the Normo (35.9 AE 5.6%) (P < 0.05, respectively). At 1 h PR, ScvO 2 in the Hypero (43.4 AE 10.2%), GIOA1 (47.2 AE 9.8%), and GIOA3 (46.0 AE 9.8%) were significantly higher than the GIOA2 (33.8 AE 7.2%) (P < 0.05, respectively). At 2 h PR, ScvO 2 in the GIOA3 (52.0 AE 10.3%) were significantly higher than the Normo (41.8 AE 9.4%) and GIOA2 (35.3 AE 9.3%) (P < 0.05, respectively); besides, ScvO 2 in the GIOA1 (49.9 AE 7.5%) were significantly higher than the GIOA2 (P < 0.05).
Effects on oxidative stress and oxygenation
Effects on blood gases
As shown in Table 1 , there was no significant difference in acid-base status between the groups at BL and PS. Arterial pH, BE, lactate, and HCO 3 À values deteriorate during hemorrhage and recovered after resuscitation. At 2 h R, pH in the Normo, Hypero, GIOA1, and GIOA3 were significantly higher than the GIOA2. And at 2 h PR, BE in the Normo, Hypero, GIOA1, and GIOA3 were significantly higher than the GIOA2. At 1 h R, arterial lactate in the Hypero, GIOA1, and GIOA3 were significantly lower than the GIOA2.
In Table 2 , arterial hemoglobin concentrations were comparable between groups at all timepoints. At 1 h R, PaO 2 in the Hypero were significantly higher than the Normo, GIOA1, GIOA2, and GIOA3. PaO 2 in the GIOA1 and GIOA3 were significantly higher than the Normo and GIOA2; in addition, PaO 2 in the GIOA1 were significantly higher than the GIOA3. At 2 h R, the PaO 2 of the Hypero and GIOA groups were significantly higher than those of the Normo. No significant differences in PaO 2 were observed at 1 h PR and 2 h PR.
Effects on hemodynamics
During HS, MAP decreased significantly to 35-40 mmHg in all of the rats (Figure 6a ). The Hypero showed a faster increase of MAP compared to the Normo and GIOA groups until 1.5 h R. MAP in the GIOA3 were significantly lower compared to the Hypero at 0.5 h R, 1 h R, and 1.5 h R, respectively (P < 0.05, respectively). At 2 h R, MAP in the GIOA2 (81.1 AE 11.5 mmHg) was significantly lower than the Hypero (92.9 AE 7.4 mmHg), the GIOA1 (89.3 AE 5.8 mmHg), and the GIOA3 (90.9 AE 7.7 mmHg), respectively (P < 0.05, respectively); and MAP in the GIOA2 was significantly higher than the Normo (70.5 AE 3.5 mmHg) (P < 0.05). Besides, at 2 h PR, MAP were significantly higher (P < 0.05) in the Hypero (77.6 AE 7.1 mmHg), GIOA1 (77.3 AE 7.9 mmHg) and GIOA3 (81.0 AE 11.7 mmHg) compared to the Normo (66.9 AE 6.9 mmHg). And MAP in the GIOA3 was significantly higher (P < 0.05) than the GIOA2 (68.8 AE 15.6 mmHg) at 2 h PR. No significant differences between the Hypero and GIOA3 were observed after 1.5 h R.
HR showed an initial fall during hemorrhage, and increased to the baseline level by the end of shock (Figure 6b ). There was no significant difference until 1 h R. No significant difference was observed at 2 h R. At 2 h PR, HR in the Hypero (491.8 AE 21.8 BPM), GIOA1 (509.8 AE 23.9 BPM), and GIOA3 (499.4 AE 20.4 BPM) was significantly higher than the Normo (471.4 AE 17.7 BPM), respectively (P < 0.05, respectively). In addition, HR in the Hypero, GIOA1, and GIOA3 was significantly higher than the GIOA2 (464.3 AE 15.2 BPM) at 2 h PR, respectively (P < 0.05, respectively).
Rate-pressure product ( Figure 6c ) was higher in the Hypero and GIOA1 compared to the Normo after 0.5 h R. After 2 h R, rate-pressure product was higher in the Hypero and GIOA3 compared to the GIOA2, and higher in the GIOA3 compared to the Normo.
Discussion
The major findings of the current study are that the GIOA3 showed improved hemodynamics and oxygenation compared to the Normo and GIOA2, meliorative oxidative stress compared to the Hypero, and reduced plasma ALT compared to the Hypero and GIOA2. The integrated effects of these factors may result in the improved survival of GIOA3 compared to the Normo, Hypero, and GIOA2.
In the present study, we did not compare hypoxemic resuscitation. This is because HS is characterized by impaired systemic/tissue oxygenation, and a high FiO 2 is imperative to supplement the oxygen deficiency. This was reflected in our previous study in that hypoxemic resuscitation did not show better results compared to the GIOA. Furthermore, hypoxemic resuscitation showed no difference in mortality compared to normoxemic resuscitation in Douzinas EE's study. 11 In addition, the current study infused LR during resuscitation rather than shed blood plus LR, as was done in our previous study; this is because blood is not available immediately in most cases. 12, 13 Concerns about whether hypoxemia at onset of resuscitation is imperative and the optimal timing of hypoxemic status exist.
GIOA1 increased FiO 2 from 0.210 to 0.500, and GIOA3 increased FiO 2 from 0.165 to 0.500. All parameters did not differ significantly between GIOA1 and GIOA3. However, at 2 h PR, MAP were comparable between GIOA1 and GIOA2, while GIOA3 was significantly higher than GIOA2; ScvO 2 were comparable between GIOA1 and Normo, while GIOA3 was significantly higher than the Normo; and no significant difference was observed between GIOA1, Normo, and Hypero in 3-NT, while GIOA3 was significantly lower than the Normo and Hypero. All of these may lead to the comparable survival of GIOA1, Normo, Hypero, and GIOA2, while the better survival of GIOA3 compared to the Normo, Hypero, and GIOA2. To be noted, GIOA1 emphasizes the gradual process, while GIOA3 not only emphasizes the gradual process, but also focuses on the hypoxemic status at the onset of reperfusion. We may thereafter conclude that the hypoxemic status at the onset of reperfusion may be imperative in the benefits of GIOA. And further research are required to determine the optimal initial FiO 2 . GIOA2 and GIOA3 both increased FiO 2 from 0.165 to 0.500; however, the hypoxemic status last 1 h in GIOA2, compared to 0.5 h in GIOA3. The liver is among the most frequently affected organs after HS. 14 In our previous study, GIOA increased liver oxygenation and decreased liver injury simultaneously. In the current study, GIOA3 showed reduced plasma ALT compared to GIOA2. Besides, GIOA3 showed better hemodynamics, acid-base balance, and survival compared to GIOA2. From these results, we may conclude that long-time hypoxemic status during resuscitation is harmful, and early moments of GIOA are critical to the benefits.
HS is associated with decreased blood flow, impaired oxygenation, increased oxidative stress, and organ dysfunction. The current biomedical strategy has developed significantly to target the unique proximal causes of the pathologies to alleviate the signs of HS. 15 For example, crystalloid and colloid are infused to supplement the blood volume during HS, and NaHCO 3 is used to treat metabolic acidosis. 16 However, these strategies treat each of the pathologies separately, 15 and a resuscitation strategy that provides multiple therapeutic effects may be preferred. Combining the results of the current study and our previous study, we can conclude that GIOA may simultaneously restore hemodynamics, ameliorate acid-base status, improve systemic/tissue oxygenation, mitigate liver oxidative stress, reduce plasma ALT, and prolong survival time.
Just like the story of oxygen in HS, asphyxiated neonates were resuscitated with oxygen since 1780. 17 However, many researchers and clinicians questioned the use of oxygen for neonatal resuscitation. Studies showed that infants resuscitated with air showed a significant benefit compared to 100% oxygen, 18 and asphyxiated neonates resuscitated with oxygen resulted in significantly higher oxidative stress compared to air. 6, 7 Thereafter, the guideline for the use of oxygen during neonatal resuscitation has been revised and recommended the use of room air since 2010. What's more, efforts have been made to investigate the effects of resuscitation with lower O 2 concentrations. 19, 20 Meanwhile, concerns have been raised that severely asphyxiated neonates resuscitated with room air may be accompanied with inadequate oxygen delivery. 21 Thus, we believe that improving oxygenation and mitigating oxidative stress simultaneously is also a critical issue in neonatal resuscitation, and GIOA (maybe from normoxia to hyperoxia) is likely to show good results.
We will study the effects of GIOA in neonatal resuscitation in our further research.
The current study has some limitations. Wistar rats were used in the study, the effects of GIOA on larger animals remain unclear. Besides, metabolomics could help identify important pathway activated by different oxygen concentration, and it is useful for monitoring the experiment. Last but not least, parameters are necessary to indicate the optimal initial oxygen concentration of GIOA and the rate FiO 2 increased. We will work on these limitations in our further research.
In conclusion, the current study showed that (1) GIOA could significantly prolong survival time compared to normoxemic resuscitation and hyperoxic resuscitation; (2) early moments of GIOA are critical to the benefits; and (3) hypoxemia at onset of resuscitation may be imperative, more works are needed to determine the optimal initial oxygen concentration of GIOA.
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